Provider review
Nova MD review
A microdose page that shows no price — the figure appears only in search results.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$99 microdose — cycle not published
Visit Nova MDA search engine is handed a number the reader on the page is not, and no billing cycle is attached to it.
Price as published
Nova MD
$99 microdose — cycle not published
FDA warning letter · Nova MD · September 2025 · addressed to Try Nova. Details in our review.
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The microdose here is a properly built product — its own page, its own intake link, and a genuinely informative explanation of the rationale and the side-effect profile. What it does not have is a visible price. The figure can show up in search results and in a comparison pop-up, but it is never printed on the page you are standing on, on a site whose other GLP-1 products advertise their twelve-month rung as the headline. Nothing tells you whether that number is a month or a year, and a warning letter is disclosed below.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a microdose sold as its own product with its own intake rather than folded into a standard program
- You want the clinical rationale and the switching guidance written out rather than assumed
- You are outside Alaska, which is the one state its GLP-1 line excludes
Look elsewhere if
- You want to see the price on the page you are buying from
- You need to know whether the figure is monthly or a year's commitment, because nothing says
- You want a metabolic specialist rather than one line inside a broad catalog
What it actually costs
Price as published
$99 microdose — cycle not published
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
78 of the 548 programs here price a small dose this way. The microdose page shows no price at all. A figure exists only in hidden search-engine markup and a comparison pop-up, so a search result can show a number you cannot see on the page, with no billing cycle attached. Every other GLP-1 product headlines its twelve-month rate, so nothing here reads as a monthly price before intake.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Sells a microdosed GLP-1 as its own product with a dedicated page, its own price and a distinct intake link rather than folding it into the standard program
- The microdose FAQ is genuinely informative about the clinical rationale, the side-effect profile and switching from standard dosing
- States GLP-1 shipping coverage precisely — all 50 states except Alaska — and publishes tighter per-product exclusions elsewhere
- Discloses in its FAQ that the advertised headline figures are twelve-month-plan rates, which many competitors never do
- Prices for the non-GLP-1 products are shown as explicit one-month versus three-month billing tables
- The terms are unusually blunt that the operator neither prescribes nor dispenses
Pharmacy, labs and oversight
Nova MD does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
0 of 4 published openly
What Nova MD publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Nova MD in September 2025. It is addressed to Try Nova — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Nova MD is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Nova MD is operated by a men's-health company under a trading name, and is a broad telehealth catalog rather than a GLP-1 specialist: weight-loss products sit alongside sermorelin, enclomiphene, NAD+, glutathione and ED medication. Its terms state plainly that it does not provide medical services, prescribe, or operate a pharmacy — prescriptions come from independent licensed providers and are filled by independent state-licensed U.S. compounding pharmacies, none of which is named. GLP-1 ships to all 50 states except Alaska. Plans run one, three, six and twelve months, and the advertised figure on each product is the twelve-month rung.
The honest cons
The microdose page renders no price at all. The $99 is fed to search engines and shown in a comparison pop-up, but never printed on the page itself — and on at least one other product the site is built to hide the price the same way
- No billing cycle is attached to the $99, and every sibling GLP-1 product advertises its twelve-month rung as the headline, so the figure cannot safely be read as a monthly price
- The advertised $109 and $149 figures are twelve-month rungs, disclosed as such only inside the FAQ rather than beside the number
- The legal entity is a men's-health company operating a weight-loss brand under a trading name, with no explanation of the relationship anywhere user-facing
- GLP-1 is one line in a catalog that also sells ED medication, so the clinical focus is diffuse rather than metabolic
- No pharmacy is ever named and no 503A or 503B designation appears, despite compounded products being the core offer
- Prescription medications are explicitly non-refundable once the prescription is written, disclosed only inside the FAQ
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Nova MD is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Nova MD does. Both are partners: we may earn a commission if you start care through these links.
Partner
Wellorithm
Compounded line not published · brand pens priced
No low-dose price published
Partner
Oak
$250–$300/mo
No low-dose price published
Where this sits
#61 of 548
Ordered with the companies that pay us first, and Nova MD is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Microdosing semaglutide
- Is compounded GLP-1 safe?
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HumeCare+
$199–$299/mo (gated)
- Vs median
- $24/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HumeCare+ review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.